-
1
-
-
0029099911
-
Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits
-
Jansen PGM, te Velthuis H, Huybregts MAJM, Paulus R, Bulder ER, van der Spoel HI, Bezemer PD, Slaats EH, Eijsman L, Wildevuur CRH. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg 1995; 110: 829-34.
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 829-834
-
-
Jansen, P.G.M.1
Te Velthuis, H.2
Huybregts, M.A.J.M.3
Paulus, R.4
Bulder, E.R.5
Van Der Spoel, H.I.6
Bezemer, P.D.7
Slaats, E.H.8
Eijsman, L.9
Wildevuur, C.R.H.10
-
2
-
-
0019418860
-
Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins
-
Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
-
(1981)
N Engl J Med
, vol.304
, pp. 497-503
-
-
Chenoweth, D.E.1
Cooper, S.W.2
Hugli, T.E.3
Stewart, R.W.4
Blackstone, E.H.5
Kirklin, J.W.6
-
3
-
-
0021051610
-
Complement and the damaging effects of cardiopulmonary bypass
-
Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
-
(1983)
J Thorac Cardiovasc Surg
, vol.86
, pp. 845-857
-
-
Kirklin, J.K.1
Westaby, S.2
Blackstone, E.H.3
Kirklin, J.W.4
Chenoweth, D.E.5
Pacifico, A.D.6
-
4
-
-
0030118055
-
Specific complement inhibition with heparin-coated extracorporeal circuits
-
te Velthuis H, Jansen PGM, Hack CE, Eijsman L, Wildevuur CRH. Specific complement inhibition with heparin-coated extracorporeal circuits. Ann Thorac Surg 1996; 61: 1153-7.
-
(1996)
Ann Thorac Surg
, vol.61
, pp. 1153-1157
-
-
Te Velthuis, H.1
Jansen, P.G.M.2
Hack, C.E.3
Eijsman, L.4
Wildevuur, C.R.H.5
-
5
-
-
8244238395
-
Clinical evaluation of Duraflo ® II heparin treated extracorporeal circulation circuits (2nd version) the European working group on heparin coated extracorporeal circulation circuits
-
Wildevuur CRH, Jansen PGM, Bezemer PD, Kuik DJ, Eijsman L, Bruins P, De Jong AP, Van Hardevelt FWJ, Biervliet JD, Hasenkam JM, et al. Clinical evaluation of Duraflo ® II heparin treated extracorporeal circulation circuits (2nd version) The European working group on heparin coated extracorporeal circulation circuits.. Eur J Cardio-thorac Surg 1997; 11: 616-23.
-
(1997)
Eur J Cardio-thorac Surg
, vol.11
, pp. 616-623
-
-
Wildevuur, C.R.H.1
Jansen, P.G.M.2
Bezemer, P.D.3
Kuik, D.J.4
Eijsman, L.5
Bruins, P.6
De Jong, A.P.7
Van Hardevelt, F.W.J.8
Biervliet, J.D.9
Hasenkam, J.M.10
-
6
-
-
0030778802
-
Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia
-
Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PGM, Van Hardevelt FWJ, de Beaumont EMFH, Wildevuur CRH, Eijsman L, Trouwborst A, Hack CE. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-8.
-
(1997)
Circulation
, vol.96
, pp. 3542-3548
-
-
Bruins, P.1
Te Velthuis, H.2
Yazdanbakhsh, A.P.3
Jansen, P.G.M.4
Van Hardevelt, F.W.J.5
De Beaumont, E.M.F.H.6
Wildevuur, C.R.H.7
Eijsman, L.8
Trouwborst, A.9
Hack, C.E.10
-
7
-
-
0016287015
-
Interactions of C-reactive protein with the complement system
-
Siegel J, Rent R, Gewurz H. Interactions of C-reactive protein with the complement system. J Exp Med 1974; 140: 631-47.
-
(1974)
J Exp Med
, vol.140
, pp. 631-647
-
-
Siegel, J.1
Rent, R.2
Gewurz, H.3
-
8
-
-
0018124055
-
C-reactive protein purification by affinity chromatography and physicochemical characterization
-
Volanakis JE, Clements WL, Schrohenloher RE. C-reactive protein purification by affinity chromatography and physicochemical characterization. J Immunol Methods 1978; 23: 285-95.
-
(1978)
J Immunol Methods
, vol.23
, pp. 285-295
-
-
Volanakis, J.E.1
Clements, W.L.2
Schrohenloher, R.E.3
-
9
-
-
0018581616
-
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
-
Volanakis JE, Wirtz KWA. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 1979; 281: 155-7.
-
(1979)
Nature
, vol.281
, pp. 155-157
-
-
Volanakis, J.E.1
Wirtz, K.W.A.2
-
10
-
-
0029927303
-
CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-CRP complexes
-
Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJM, Hack CE. CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-CRP complexes. J Immunol 1996; 157: 473-9.
-
(1996)
J Immunol
, vol.157
, pp. 473-479
-
-
Wolbink, G.J.1
Brouwer, M.C.2
Buysmann, S.3
Ten Berge, I.J.M.4
Hack, C.E.5
-
11
-
-
0017228286
-
Assay of heparin in plasma using a chromogenic substrate for activated factor X
-
Teien AM, Lie M, Abildgaard U. Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 1976; 8: 413-6.
-
(1976)
Thromb Res
, vol.8
, pp. 413-416
-
-
Teien, A.M.1
Lie, M.2
Abildgaard, U.3
-
12
-
-
0025269302
-
In vitro effect on heptest ® of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities
-
Bara L, Mardiguian J, Samama M. In vitro effect on heptest ® of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities. Thromb Res 1990; 57 (4): 585-92.
-
(1990)
Thromb Res
, vol.57
, Issue.4
, pp. 585-592
-
-
Bara, L.1
Mardiguian, J.2
Samama, M.3
-
13
-
-
0027179963
-
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway
-
Wolbink GJ, Bollen J, Baars JW, ten Berge RJM, Swaak AJG, Paardekooper J, Hack CE. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 1993; 163: 67-76.
-
(1993)
J Immunol Methods
, vol.163
, pp. 67-76
-
-
Wolbink, G.J.1
Bollen, J.2
Baars, J.W.3
Ten Berge, R.J.M.4
Swaak, A.J.G.5
Paardekooper, J.6
Hack, C.E.7
-
14
-
-
0025291095
-
Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3"
-
Hack CE, Paardekooper J, Van Milligen F. Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3". J Immunol 1990; 144: 4249-55.
-
(1990)
J Immunol
, vol.144
, pp. 4249-4255
-
-
Hack, C.E.1
Paardekooper, J.2
Van Milligen, F.3
-
16
-
-
0023795421
-
Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies
-
Hack CE, Paardekooper J, Smeenk RJT, Abbink JJ, Eerenberg AJM, Nuijens J. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J Immunol 1988; 141: 1602-9.
-
(1988)
J Immunol
, vol.141
, pp. 1602-1609
-
-
Hack, C.E.1
Paardekooper, J.2
Smeenk, R.J.T.3
Abbink, J.J.4
Eerenberg, A.J.M.5
Nuijens, J.6
-
17
-
-
0016435864
-
Complement activation by interaction of polyanions and polycations: Heparin-protamine induced consumption of complement
-
Rent R, Eisenstein R, Gewarz H. Complement activation by interaction of polyanions and polycations: Heparin-protamine induced consumption of complement. J Immunol 1975; 114 (1): 120-4.
-
(1975)
J Immunol
, vol.114
, Issue.1
, pp. 120-124
-
-
Rent, R.1
Eisenstein, R.2
Gewarz, H.3
-
18
-
-
0022627564
-
Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state
-
Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW, Bitran DD, Curd JG, Reves JG, Samuelson PN. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state. Ann Thorac Surg 1986; 41: 193-9.
-
(1986)
Ann Thorac Surg
, vol.41
, pp. 193-199
-
-
Kirklin, J.K.1
Chenoweth, D.E.2
Naftel, D.C.3
Blackstone, E.H.4
Kirklin, J.W.5
Bitran, D.D.6
Curd, J.G.7
Reves, J.G.8
Samuelson, P.N.9
-
19
-
-
0021362586
-
Complement activation during cardiopulmonary bypass by heparin-protamine interaction
-
Best N, Sinosich MJ, Grunzinskas JG, Fisher M. Complement activation during cardiopulmonary bypass by heparin-protamine interaction. Br J Anaesth 1984; 56: 339-43.
-
(1984)
Br J Anaesth
, vol.56
, pp. 339-343
-
-
Best, N.1
Sinosich, M.J.2
Grunzinskas, J.G.3
Fisher, M.4
-
20
-
-
0033396705
-
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
-
Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB. C-reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction. J Exp Med 1999; 190: 1733-40.
-
(1999)
J Exp Med
, vol.190
, pp. 1733-1740
-
-
Griselli, M.1
Herbert, J.2
Hutchinson, W.L.3
Taylor, K.M.4
Sohail, M.5
Krausz, T.6
Pepys, M.B.7
-
21
-
-
0027175408
-
Complement activation during OKT3 treatment: A possible explanation for respiratory side effects
-
Raasveld MH, Bemelman FJ, Schellekens PT, van Diepen FN, van Dongen Av, Royen EA, Hack CE, ten Berge IJ. Complement activation during OKT3 treatment: a possible explanation for respiratory side effects. Kidney Int 1993; 43: 1140-9.
-
(1993)
Kidney Int
, vol.43
, pp. 1140-1149
-
-
Raasveld, M.H.1
Bemelman, F.J.2
Schellekens, P.T.3
Van Diepen, F.N.4
Van Dongen, Av.5
Royen, E.A.6
Hack, C.E.7
Ten Berge, I.J.8
-
22
-
-
0023175684
-
Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement
-
van Dam AP, Hack CE. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement. Immunol 1987; 61: 105-10.
-
(1987)
Immunol
, vol.61
, pp. 105-110
-
-
Van Dam, A.P.1
Hack, C.E.2
-
23
-
-
0031106565
-
A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells
-
Hack CE, Wolhink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 1997; 18: 111-5.
-
(1997)
Immunol Today
, vol.18
, pp. 111-115
-
-
Hack, C.E.1
Wolhink, G.J.2
Schalkwijk, C.3
Speijer, H.4
Hermens, W.T.5
Van Den Bosch, H.6
-
24
-
-
0031957537
-
Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypass
-
Bruins P, te Velthuis H, Jansen PGM, Eijsman L, Hack CE. Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 115 (4): 949-51.
-
(1998)
J Thorac Cardiovasc Surg
, vol.115
, Issue.4
, pp. 949-951
-
-
Bruins, P.1
Te Velthuis, H.2
Jansen, P.G.M.3
Eijsman, L.4
Hack, C.E.5
-
25
-
-
0018962610
-
Binding reactivity of C-reactive protein for polycations
-
DiCamelli R, Potempa LA, Siegel J, Suyehira L, Petras K, Gewurz H. Binding reactivity of C-reactive protein for polycations. J Immunol 1980; 125: 1933-8.
-
(1980)
J Immunol
, vol.125
, pp. 1933-1938
-
-
DiCamelli, R.1
Potempa, L.A.2
Siegel, J.3
Suyehira, L.4
Petras, K.5
Gewurz, H.6
-
26
-
-
0016748392
-
Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations
-
Siegel J, Osmand AP, Wilson MF, Gewurz H. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J Exp Med 1975; 142: 709-21.
-
(1975)
J Exp Med
, vol.142
, pp. 709-721
-
-
Siegel, J.1
Osmand, A.P.2
Wilson, M.F.3
Gewurz, H.4
-
27
-
-
0343894289
-
Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells
-
Oz MC, Liao H, Naka Y, Seldomridge A, Becker DN, Michler RE, Smith CR, Rose EA, Stern DM, Pinsky DJ. Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 1995; 92: 11428-32.
-
(1995)
Circulation
, vol.92
, pp. 11428-11432
-
-
Oz, M.C.1
Liao, H.2
Naka, Y.3
Seldomridge, A.4
Becker, D.N.5
Michler, R.E.6
Smith, C.R.7
Rose, E.A.8
Stern, D.M.9
Pinsky, D.J.10
|